A common blood pressure medication demonstrates effectiveness against methicillin-resistant Staphylococcus aureus (MRSA), according to research published in Nature Communications. The discovery offers hope in combating antibiotic-resistant bacteria, which cause over 2.8 million infections and more than 35,000 deaths annually in the United States. These drug-resistant infections are notoriously difficult to treat with conventional antibiotics. The blood pressure drug could serve as the basis for new treatments, representing a potential breakthrough in addressing one of modern medicine's most pressing challenges.
Antibiotic-Resistant Bacteria as a Public Health Crisis
- ▪Antibiotic-resistant bacteria are responsible for more than 35,000 deaths in the U.S. each year
- ▪Infections from antibiotic-resistant bacteria are difficult to treat
- ▪Antibiotic-resistant bacteria are responsible for over 2.8 million infections in the U.S. each year
Blood Pressure Drug as Potential MRSA Treatment
- ▪A blood pressure drug shows effectiveness against methicillin-resistant Staphylococcus aureus
- ▪A study in Nature Communications reports that a blood pressure drug could be the basis of a treatment for methicillin-resistant Staphylococcus aureus
Perspective of Researchers studying antibiotic alternatives
- ▪Repurposing existing blood pressure medications could provide a faster pathway to treating antibiotic-resistant infections than developing new antibiotics
- ▪The blood pressure drug represents a potential new weapon against drug-resistant infections
Story comments
Loading comments…